Impact of erythropoietin treatment on the quality of life of oncologic patients (Q36987497)

17 August 2017

1 reference

title

Impact of erythropoietin treatment on the quality of life of oncologic patients (English)

1 reference

17 August 2017

1 reference

1 reference

Pelegrí A

1

1 reference

17 August 2017

1 October 2007

1 reference

Clinical and Translational Oncology

17 August 2017

1 reference

17 August 2017

9

1 reference

17 August 2017

10

1 reference

17 August 2017

645-651

1 reference

https://scigraph.springernature.com/pub.10.1007/s12094-007-0117-1

17 August 2017

0 references

cites work

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-007-0117-1

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

21 January 2018

1 reference

12 December 2020

Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial.

1 reference

12 December 2020

Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.

1 reference

12 December 2020

The impact of hemoglobin levels on fatigue and quality of life in cancer patients.

1 reference

12 December 2020

Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial

1 reference

12 December 2020

Psychological outcomes associated with anemia-related fatigue in cancer patients

1 reference

12 December 2020

Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales

1 reference

12 December 2020

Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.

1 reference

12 December 2020

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 reference

12 December 2020

Chemotherapy-induced cognitive dysfunction: a clearer picture

1 reference

12 December 2020

Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

1 reference

12 December 2020

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.

1 reference

12 December 2020

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology

1 reference

12 December 2020

Prevalence and outcomes of anemia in cancer: a systematic review of the literature

1 reference

12 December 2020

Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies

1 reference

12 December 2020

Impact of epoetin beta on quality of life in patients with malignant disease

1 reference

12 December 2020

Factors influencing quality of life in cancer patients: anemia and fatigue.

1 reference

12 December 2020

Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis

1 reference

12 December 2020

Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia.

1 reference

12 December 2020

Guidelines for the use of epoetin: have quality-of-life benefits been proven?

1 reference

12 December 2020

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.

1 reference

12 December 2020

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1 reference

12 December 2020

The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

1 reference

12 December 2020

The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue

1 reference

12 December 2020

The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials

1 reference

12 December 2020

Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapy

1 reference

12 December 2020

Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer

1 reference

12 December 2020

Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial

1 reference

12 December 2020

Symptomatology of anemia

1 reference

12 December 2020

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.

1 reference

12 December 2020

Weighing the hazards of erythropoiesis stimulation in patients with cancer

1 reference

12 December 2020

Chemotherapy-induced anemia in adults: incidence and treatment

1 reference

12 December 2020

A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer.

1 reference

12 December 2020

Evaluating erythropoietic agents for the treatment of anaemia in the oncology setting

1 reference

12 December 2020

Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy.

1 reference

12 December 2020

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

1 reference

12 December 2020

10.1007/S12094-007-0117-1

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17974525